Related Experiment Videos
A new synthetic peptide with elastase inhibiting effect.
L Galzigna1, F Marchiori, M Celadin
1Institute of Biological Chemistry, University of Padova, Italy.
Biomedica Biochimica Acta
|January 1, 1989
Summary
A novel synthetic peptide effectively inhibits both porcine pancreatic elastase and human plasma elastase. This peptide demonstrates a dose-dependent inhibitory effect, showing promise as a potential therapeutic agent.
Area of Science:
- Biochemistry
- Pharmacology
Background:
- Elastase enzymes play crucial roles in physiological processes.
- Dysregulation of elastase activity is implicated in various diseases.
- Alpha-1-antitrypsin is a key inhibitor of human plasma elastase.
Purpose of the Study:
- To synthesize and characterize a novel peptide inhibitor.
- To evaluate the inhibitory activity of the peptide against porcine pancreatic elastase.
- To assess the peptide's efficacy on human plasma elastase in varying concentrations of alpha-1-antitrypsin.
Main Methods:
- Chemical synthesis of a novel peptide.
- In vitro inhibition assays for porcine pancreatic elastase.
- Immunoenzymatic assays to measure human plasma elastase activity.
- Testing in human plasma with different levels of alpha-1-antitrypsin.
Main Results:
- The synthetic peptide inhibited porcine pancreatic elastase in vitro with an IC50 of 24 µmol/l.
- The peptide demonstrated a dose-dependent decrease in normal human plasma elastase activity with an IC50 of 13 µmol/l.
- In plasma with elevated alpha-1-antitrypsin levels, the peptide's IC50 for human plasma elastase was 18 µmol/l.
Conclusions:
- The novel synthetic peptide exhibits significant inhibitory activity against both porcine pancreatic elastase and human plasma elastase.
- The peptide's efficacy is maintained in the presence of alpha-1-antitrypsin, suggesting potential therapeutic applications.
- Further research is warranted to explore the therapeutic potential of this peptide in elastase-related conditions.